330 related articles for article (PubMed ID: 16060128)
21. Neoral dose adjustment after conversion from C0 to C2 monitoring in stable renal transplant recipients: a prospective single center study.
Sandrini S; Bossini N; Setti G; Mazzucchelli C; Maiorca P; Cancarini G
J Nephrol; 2004; 17(2):284-90. PubMed ID: 15293530
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of changing from cyclosporine C0 to C2 monitoring in stable recipients following renal transplantation: a prospective cohort study.
Zhang Y; Zhang XD; Wang Y
Transplant Proc; 2011 Dec; 43(10):3697-701. PubMed ID: 22172829
[TBL] [Abstract][Full Text] [Related]
23. C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
Midtvedt K; Fauchald P; Bergan S; Høieggen A; Hallan S; Svarstad E; Bergrem H; Eriksen BO; Pfeffer PF; Dalen I; Leivestad T
Transplantation; 2003 Oct; 76(8):1236-8. PubMed ID: 14578761
[TBL] [Abstract][Full Text] [Related]
24. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
25. [A new strategy for monitoring levels of cyclosporin A in the blood of patients after kidney transplantation].
Halacová M; Jedlicková B; Průsa R
Ceska Slov Farm; 2003 Nov; 52(6):267-71. PubMed ID: 14661365
[TBL] [Abstract][Full Text] [Related]
26. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral.
Al Wakeel JS; Shaheen FA; Mathew MC; Abou Zeinab HM; Al Alfi A; Tarif NM; Al Mousawi MS; Mahmoud TS; Alorrayed AS; Fagir EA; Dham RS; Shaker DS
Transplant Proc; 2008 Sep; 40(7):2245-51. PubMed ID: 18790205
[TBL] [Abstract][Full Text] [Related]
27. Cyclosporine profiling with C2 and C0 monitoring improves outcomes after heart transplantation.
Barnard JB; Thekkudan J; Richardson S; Bittar MN; Martyszczuck R; Hasan J; Khasati N; Keevil B; Yonan N
J Heart Lung Transplant; 2006 May; 25(5):564-8. PubMed ID: 16678036
[TBL] [Abstract][Full Text] [Related]
28. Cyclosporine C2 target levels and acute cellular rejection after lung transplantation.
Glanville AR; Aboyoun CL; Morton JM; Plit M; Malouf MA
J Heart Lung Transplant; 2006 Aug; 25(8):928-34. PubMed ID: 16890113
[TBL] [Abstract][Full Text] [Related]
29. Long-term benefits and risks of cyclosporin A (sandimmun)--an analysis at 10 years.
Thiel G; Bock A; Spöndlin M; Brunner FP; Mihatsch M; Rufli T; Landmann J
Transplant Proc; 1994 Oct; 26(5):2493-8. PubMed ID: 7940765
[TBL] [Abstract][Full Text] [Related]
30. Experience with cyclosporine: approaching the therapeutic window for C2 levels in maintenance kidney transplant recipients.
Di Paolo S; Teutonico A; Infante B; Stallone G; Schena A; Grandaliano G; Battaglia M; Di Tonno P; Schena FP
Transplant Proc; 2004 Mar; 36(2 Suppl):434S-436S. PubMed ID: 15041381
[TBL] [Abstract][Full Text] [Related]
31. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcomes and C2 cyclosporin monitoring in maintenance renal transplant recipients: 1 year follow-up study.
Marcén R; Villafruela JJ; Pascual J; Teruel JL; Ocaña J; Tenorio MT; Burgos FJ; Ortuño J
Nephrol Dial Transplant; 2005 Apr; 20(4):803-10. PubMed ID: 15687111
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy of therapeutic monitoring of cyclosporine through C2 and AUC(0-4) during the first 24 months following kidney transplantation].
Vavić N; Ignjatović L; Drasković B; Hrvacević R; Kovacević Z; Paunić Z
Vojnosanit Pregl; 2008 Feb; 65(2):119-27. PubMed ID: 18365668
[TBL] [Abstract][Full Text] [Related]
34. Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine A in renal transplantation.
Bunnag S; Vareesangthip K; Ong-ajyooth L
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S228-34. PubMed ID: 17044476
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic.
Brunet M; Crespo M; Millán O; Serón D; Torregrosa V; Jiménez O; Moreso F; Martorell J; Grinyo JM; Oppenheimer F
Transplant Proc; 2007 Sep; 39(7):2160-2. PubMed ID: 17889124
[TBL] [Abstract][Full Text] [Related]
36. Cyclosporine C2 levels in de novo renal allograft recipients: a German multicenter prospective observational study.
Arns W; Zantvoort F; Abendroth D; Seiter H; Scheuermann EH; Albert U; Stahl R; Fornara P; Fricke L; Neumayer HH; Nagel E; Michel U; Ulbricht B
Transplant Proc; 2005 Apr; 37(3):1612-5. PubMed ID: 15866687
[TBL] [Abstract][Full Text] [Related]
37. Mycophenolate sodium increases cyclosporine blood levels in renal transplant recipients.
Pourfarziani V; Taheri S
Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):991-4. PubMed ID: 19861858
[TBL] [Abstract][Full Text] [Related]
38. Correlations between cyclosporine concentrations at 2 hours post-dose and trough levels with functional outcomes in de novo lung transplant recipients.
Maziers N; Bulpa P; Jamart J; Delaunois L; Eucher P; Evrard P
Transplant Proc; 2012 Nov; 44(9):2880-4. PubMed ID: 23146546
[TBL] [Abstract][Full Text] [Related]
39. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
Tanaka K; Lake J; Villamil F; Levy G; Marotta P; Mies S; de Hemptinne B; Moench C
Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691
[TBL] [Abstract][Full Text] [Related]
40. Utility of c2 monitoring in prediction of diastolic dysfunction in renal transplant recipients.
Kirkpantur A; Yilmaz R; Abali G; Arici M; Altun B; Aki T; Erkan I; Bakkaloglu M; Yasavul U; Turgan C
Transplant Proc; 2008; 40(1):171-3. PubMed ID: 18261577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]